‘Imminent’ Gilenya ANDA Launches Halted By US Supreme Court
Favorable Federal Circuit Ruling Is Overturned By Highest Federal Court
In a dramatic twist, Gilenya ANDA sponsors are now unable to launch their generic products in the US after the US Supreme Court intervened in favor of originator Novartis, superseding the US Federal Circuit.
